Literature DB >> 23750491

Systematic review and meta-analysis of the role of vascular resection in the treatment of hilar cholangiocarcinoma.

Saleh Abbas1, Charbel Sandroussi.   

Abstract

BACKGROUND: The management of hilar cholangiocarcinoma has evolved over time and extended liver resection, including the caudate lobe, and major vascular resection and extended lymphadenectomy have become established practice. The benefit of vascular resection has not been investigated.
METHODS: A systematic search of the MEDLINE and EMBASE databases was used to identify studies. A systematic review and a meta-analysis of the available studies were conducted according to PRISMA guidelines. Odds ratios were calculated using the Mantel-Haenszel method. Primary outcome variables assessed included morbidity, mortality, vascular complications and the effect of vascular resection on longterm survival.
RESULTS: Of 411 search results, only 24 studies reported the results of vascular resection in hilar cholangiocarcinoma. Meta-analysis showed increased morbidity and mortality with hepatic artery resection. Portal vein resection was achievable with no impact on postoperative mortality. Vascular resection did not improve negative margin rates and had no impact on longterm survival.
CONCLUSIONS: Portal vein resection does not preclude curative resection; however, it is not routinely recommended unless there is suspicion of tumour invasion. There was no proven survival advantage with portal vein resection. Arterial resection results in higher morbidity and mortality with no proven benefit.
© 2013 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2013        PMID: 23750491      PMCID: PMC3692018          DOI: 10.1111/j.1477-2574.2012.00616.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  43 in total

1.  Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience.

Authors:  J I Tsao; Y Nimura; J Kamiya; N Hayakawa; S Kondo; M Nagino; M Miyachi; M Kanai; K Uesaka; K Oda; R L Rossi; J W Braasch; J M Dugan
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

2.  Liver regeneration after major hepatectomy for biliary cancer.

Authors:  M Nagino; M Ando; J Kamiya; K Uesaka; T Sano; Y Nimura
Journal:  Br J Surg       Date:  2001-08       Impact factor: 6.939

3.  Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.

Authors:  W R Jarnagin; Y Fong; R P DeMatteo; M Gonen; E C Burke; J Bodniewicz BS; M Youssef BA; D Klimstra; L H Blumgart
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

4.  Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection.

Authors:  Luis Muñoz; Sasan Roayaie; Daniel Maman; Thomas Fishbein; Patricia Sheiner; Sukru Emre; Charles Miller; Myron E Schwartz
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

5.  Extended resections for hilar cholangiocarcinoma.

Authors:  P Neuhaus; S Jonas; W O Bechstein; R Lohmann; C Radke; N Kling; C Wex; H Lobeck; R Hintze
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

6.  One hundred and eleven liver resections for hilar bile duct cancer.

Authors:  S G Lee; Y J Lee; K M Park; S Hwang; P C Min
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

7.  Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience.

Authors:  Y Nimura; J Kamiya; S Kondo; M Nagino; K Uesaka; K Oda; T Sano; H Yamamoto; N Hayakawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

8.  Portal vein resection in management of hilar cholangiocarcinoma.

Authors:  Alan W Hemming; Kristin Mekeel; Ajai Khanna; Angeles Baquerizo; Robin D Kim
Journal:  J Am Coll Surg       Date:  2011-04       Impact factor: 6.113

9.  Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.

Authors:  Tomoki Ebata; Masato Nagino; Junichi Kamiya; Katsuhiko Uesaka; Tetsuro Nagasaka; Yuji Nimura
Journal:  Ann Surg       Date:  2003-11       Impact factor: 12.969

10.  Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality.

Authors:  Peter Neuhaus; Sven Jonas; Utz Settmacher; Armin Thelen; Christoph Benckert; Enrique Lopez-Hänninen; Rainer E Hintze
Journal:  Langenbecks Arch Surg       Date:  2003-06-18       Impact factor: 3.445

View more
  33 in total

1.  Bile duct surgery in the treatment of hepatobiliary and gallbladder malignancies: effects of hepatic and vascular resection on outcomes.

Authors:  Perry Shen; Nora Fino; Edward A Levine; Pamela Eversole; Clancy Clark
Journal:  HPB (Oxford)       Date:  2015-09-16       Impact factor: 3.647

Review 2.  [Vascular reconstruction in hepatic surgery].

Authors:  S Heinrich; J Baumgart; J Mittler; H Lang
Journal:  Chirurg       Date:  2016-02       Impact factor: 0.955

Review 3.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

4.  Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for "Borderline Resectable" in the Field of Surgery for Hilar Cholangiocarcinoma.

Authors:  Ryusei Matsuyama; Daisuke Morioka; Ryutaro Mori; Yasuhiro Yabushita; Seigo Hiratani; Yohei Ota; Takafumi Kumamoto; Itaru Endo
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

Review 5.  Evolving role of vascular resection and reconstruction in hepatic surgery for malignancy.

Authors:  Kristin L Mekeel; Alan W Hemming
Journal:  Hepat Oncol       Date:  2013-12-20

Review 6.  Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.

Authors:  Irinel Popescu; Traian Dumitrascu
Journal:  Langenbecks Arch Surg       Date:  2014-05-20       Impact factor: 3.445

7.  Surgical Site Infection Is Associated with Tumor Recurrence in Patients with Extrahepatic Biliary Malignancies.

Authors:  Stefan Buettner; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Matthew Weiss; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Bas Groot Koerkamp; Shishir K Maithel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2017-09-14       Impact factor: 3.452

8.  Total Hilar En Bloc Resection with Left Hemihepatectomy and Caudate Lobectomy: a Novel Approach for Treatment of Left-Sided Perihilar Cholangiocarcinoma (with Video).

Authors:  Cai De Lu; Jing Huang; Sheng Dong Wu; Yong Fei Hua; Ammar A Javed; Jiong Zhe Fang; Chun Nian Wang; Sheng Ye
Journal:  J Gastrointest Surg       Date:  2017-09-05       Impact factor: 3.452

Review 9.  Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Authors:  Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

10.  Liver resection for perihilar cholangiocarcinoma - why left is sometimes right.

Authors:  Sanjay Govil; Anand Bharatan; Ashwin Rammohan; Rathnavel Kanagavelu; Ilankumaran Kaliamoorthy; Mettu S Reddy; Mohamed Rela
Journal:  HPB (Oxford)       Date:  2016-05-26       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.